Literature DB >> 25492866

Cohen syndrome-associated protein COH1 physically and functionally interacts with the small GTPase RAB6 at the Golgi complex and directs neurite outgrowth.

Wenke Seifert1, Jirko Kühnisch2, Tanja Maritzen3, Stefanie Lommatzsch4, Hans Christian Hennies5, Sebastian Bachmann4, Denise Horn6, Volker Haucke3.   

Abstract

Postnatal microcephaly, intellectual disability, and progressive retinal dystrophy are major features of autosomal recessive Cohen syndrome, which is caused by mutations in the gene COH1 (VPS13B). We have recently identified COH1 as a Golgi-enriched scaffold protein that contributes to the structural maintenance and function of the Golgi complex. Here, we show that association of COH1 with the Golgi complex depends on the small GTPase RAB6. RNAi-mediated knockdown of RAB6A/A' prevents the localization of COH1 to the Golgi complex. Expression of the constitutively inactive RAB6_T27N mutant led to an increased solubilization of COH1 from lipid membrane preparations. Co-IP experiments confirmed the physical interaction of COH1 with RAB6 that preferentially occurred with the constitutively active RAB6_Q72L mutants. Depletion of COH1 in primary neurons negatively interfered with neurite outgrowth, indicating a causal link between the integrity of the Golgi complex and axonal outgrowth. We conclude that COH1 is a RAB6 effector protein and that reduced brain size in Cohen syndrome patients likely results from impaired COH1 function at the Golgi complex, causing decreased neuritogenesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  COH1; Cohen Syndrome; GTPase; Genetic Disease; Golgi; Neurite Outgrowth; Protein-Protein Interaction; RAB6

Mesh:

Substances:

Year:  2014        PMID: 25492866      PMCID: PMC4319006          DOI: 10.1074/jbc.M114.608174

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport.

Authors:  Juha Kolehmainen; Graeme C M Black; Anne Saarinen; Kate Chandler; Jill Clayton-Smith; Ann-Liz Träskelin; Rahat Perveen; Satu Kivitie-Kallio; Reijo Norio; Mette Warburg; Jean-Pierre Fryns; Albert de la Chapelle; Anna-Elina Lehesjoki
Journal:  Am J Hum Genet       Date:  2003-05-02       Impact factor: 11.025

3.  Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome.

Authors:  Hans Christian Hennies; Anita Rauch; Wenke Seifert; Christian Schumi; Elisabeth Moser; Eva Al-Taji; Gholamali Tariverdian; Krystyna H Chrzanowska; Malgorzata Krajewska-Walasek; Anna Rajab; Roberto Giugliani; Thomas E Neumann; Katja M Eckl; Mohsen Karbasiyan; André Reis; Denise Horn
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

4.  Broader geographical spectrum of Cohen syndrome due to COH1 mutations.

Authors:  G H Mochida; A Rajab; W Eyaid; A Lu; D Al-Nouri; K Kosaki; M Noruzinia; P Sarda; J Ishihara; A Bodell; K Apse; C A Walsh
Journal:  J Med Genet       Date:  2004-06       Impact factor: 6.318

Review 5.  Cortical neuronal migration mutants suggest separate but intersecting pathways.

Authors:  Stephanie Bielas; Holden Higginbotham; Hiroyuki Koizumi; Teruyuki Tanaka; Joseph G Gleeson
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

6.  Analysis of the human VPS13 gene family.

Authors:  Antonio Velayos-Baeza; Andrea Vettori; Richard R Copley; Carol Dobson-Stone; A P Monaco
Journal:  Genomics       Date:  2004-09       Impact factor: 5.736

7.  Distinct sets of Rab6 effectors contribute to ZW10--and COG-dependent Golgi homeostasis.

Authors:  Waqar Majeed; Shijie Liu; Brian Storrie
Journal:  Traffic       Date:  2014-04-11       Impact factor: 6.215

8.  Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Nicholas B Miliaras; Alex Kazantsev; Yury O Chernoff; J Michael McCaffery; Beverly Wendland; Michael Y Sherman
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex.

Authors:  Volney L Sheen; Vijay S Ganesh; Meral Topcu; Guillaume Sebire; Adria Bodell; R Sean Hill; P Ellen Grant; Yin Yao Shugart; Jaime Imitola; Samia J Khoury; Renzo Guerrini; Christopher A Walsh
Journal:  Nat Genet       Date:  2003-11-30       Impact factor: 38.330

10.  Sfi1p has conserved centrin-binding sites and an essential function in budding yeast spindle pole body duplication.

Authors:  John V Kilmartin
Journal:  J Cell Biol       Date:  2003-09-22       Impact factor: 10.539

View more
  31 in total

1.  Drosophila Vps13 Is Required for Protein Homeostasis in the Brain.

Authors:  Jan J Vonk; Wondwossen M Yeshaw; Francesco Pinto; Anita I E Faber; Liza L Lahaye; Bart Kanon; Marianne van der Zwaag; Antonio Velayos-Baeza; Raimundo Freire; Sven C van IJzendoorn; Nicola A Grzeschik; Ody C M Sibon
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 2.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

Review 3.  Role of VPS13, a protein with similarity to ATG2, in physiology and disease.

Authors:  Berrak Ugur; William Hancock-Cerutti; Marianna Leonzino; Pietro De Camilli
Journal:  Curr Opin Genet Dev       Date:  2020-06-18       Impact factor: 5.578

4.  Vps13b is required for acrosome biogenesis through functions in Golgi dynamic and membrane trafficking.

Authors:  Romain Da Costa; Morgane Bordessoules; Magali Guilleman; Virginie Carmignac; Vincent Lhussiez; Hortense Courot; Amandine Bataille; Amandine Chlémaire; Céline Bruno; Patricia Fauque; Christel Thauvin; Laurence Faivre; Laurence Duplomb
Journal:  Cell Mol Life Sci       Date:  2019-06-19       Impact factor: 9.261

Review 5.  Dysregulation of organelle membrane contact sites in neurological diseases.

Authors:  Soojin Kim; Robert Coukos; Fanding Gao; Dimitri Krainc
Journal:  Neuron       Date:  2022-05-12       Impact factor: 18.688

6.  Changes in the expression of the type 2 diabetes-associated gene VPS13C in the β-cell are associated with glucose intolerance in humans and mice.

Authors:  Zenobia B Mehta; Nicholas Fine; Timothy J Pullen; Matthew C Cane; Ming Hu; Pauline Chabosseau; Gargi Meur; Antonio Velayos-Baeza; Anthony P Monaco; Lorella Marselli; Piero Marchetti; Guy A Rutter
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-06-21       Impact factor: 4.310

7.  Exome sequencing identifies pathogenic variants of VPS13B in a patient with familial 16p11.2 duplication.

Authors:  Jila Dastan; Chieko Chijiwa; Flamingo Tang; Sally Martell; Ying Qiao; Evica Rajcan-Separovic; M E Suzanne Lewis
Journal:  BMC Med Genet       Date:  2016-11-10       Impact factor: 2.103

8.  The Vps13p-Cdc31p complex is directly required for TGN late endosome transport and TGN homotypic fusion.

Authors:  Mithu De; Austin N Oleskie; Mariam Ayyash; Somnath Dutta; Liliya Mancour; Mohamed E Abazeed; Eddy J Brace; Georgios Skiniotis; Robert S Fuller
Journal:  J Cell Biol       Date:  2017-01-25       Impact factor: 10.539

Review 9.  Cohen Syndrome: Review of the Literature.

Authors:  Jonathan M Rodrigues; Hermina D Fernandes; Carrie Caruthers; Stephen R Braddock; Alan P Knutsen
Journal:  Cureus       Date:  2018-09-18

10.  Competitive organelle-specific adaptors recruit Vps13 to membrane contact sites.

Authors:  Björn D M Bean; Samantha K Dziurdzik; Kathleen L Kolehmainen; Claire M S Fowler; Waldan K Kwong; Leslie I Grad; Michael Davey; Cayetana Schluter; Elizabeth Conibear
Journal:  J Cell Biol       Date:  2018-07-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.